S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  • Interventional
  • Active
  • NCT01120249

EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study

RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor. PURPOSE: This phase III trial is studying everolimus to see how well it works in treating patients with kidney cancer who have undergone surgery.